- Home
- FTHM vs GDTC Comparison
FTHM vs GDTC Comparison
Compare FTHM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- GDTC
- Stock Information
- Founded
- FTHM 2010
- GDTC 2018
- Country
- FTHM United States
- GDTC Singapore
- Employees
- FTHM N/A
- GDTC N/A
- Industry
- FTHM Real Estate
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- GDTC Health Care
- Exchange
- FTHM Nasdaq
- GDTC Nasdaq
- Market Cap
- FTHM 38.3M
- GDTC 21.5M
- IPO Year
- FTHM 2020
- GDTC 2023
- Fundamental
- Price
- FTHM $2.75
- GDTC $1.93
- Analyst Decision
- FTHM
- GDTC Buy
- Analyst Count
- FTHM 0
- GDTC 1
- Target Price
- FTHM N/A
- GDTC $5.00
- AVG Volume (30 Days)
- FTHM 1.5M
- GDTC 14.1K
- Earning Date
- FTHM 11-06-2025
- GDTC 01-01-0001
- Dividend Yield
- FTHM N/A
- GDTC N/A
- EPS Growth
- FTHM N/A
- GDTC N/A
- EPS
- FTHM N/A
- GDTC N/A
- Revenue
- FTHM $390,032,000.00
- GDTC $368,838.00
- Revenue This Year
- FTHM $25.22
- GDTC $5.37
- Revenue Next Year
- FTHM $16.19
- GDTC N/A
- P/E Ratio
- FTHM N/A
- GDTC N/A
- Revenue Growth
- FTHM 19.16
- GDTC N/A
- 52 Week Low
- FTHM $0.65
- GDTC $1.20
- 52 Week High
- FTHM $3.37
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- FTHM 67.86
- GDTC 51.25
- Support Level
- FTHM $1.80
- GDTC N/A
- Resistance Level
- FTHM $3.09
- GDTC $2.27
- Average True Range (ATR)
- FTHM 0.35
- GDTC 0.10
- MACD
- FTHM 0.09
- GDTC -0.06
- Stochastic Oscillator
- FTHM 75.18
- GDTC 85.02
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.